PRESS RELEASE published on 07/22/2025 at 17:45, 1 year 3 months ago Amoéba signs an agreement with Metron Technology, a subsidiary of Oriental Beauty Valley (OBV), a key player in the cosmetics industry in China Amoéba signs agreement with Metron Technology, subsidiary of Oriental Beauty Valley, for cosmetic ingredient in China. Accelerating entry into second largest cosmetics market AMOEBA China Metron Technology Oriental Beauty Valley Cosmetic Ingredient
BRIEF published on 06/25/2025 at 08:50, 1 year 4 months ago Dérogation obtenue par Amoéba pour son produit de biocontrôle AXP12 AMOEBA Biocontrôle Dérogation AXP12 ANSES
BRIEF published on 06/25/2025 at 08:50, 1 year 4 months ago Exemption obtained by Amoéba for its biocontrol product AXP12 AMOEBA Biocontrol Exemption AXP12 ANSES
PRESS RELEASE published on 06/25/2025 at 08:45, 1 year 4 months ago Dérogation à l'obligation de destruction des récoltes en France obtenue par Amoéba Amoéba reçoit une dérogation d'ANSES pour essais avec biocontrôle AXP12 contre maladies des cultures. Avancée majeure pour la greentech dans le domaine du biocontrôle et autorisations en cours AMOEBA Biocontrôle Dérogation ANSES Maladies Des Cultures
PRESS RELEASE published on 06/25/2025 at 08:45, 1 year 4 months ago Exemption from the obligation to destroy crops in France obtained by Amoéba Amoéba receives experimental permit from ANSES for biocontrol product 'AXP12' against various crop diseases, exempt from crop destruction, marking significant progress in environmental-friendly solutions AMOEBA Biocontrol Environmentally Friendly ANSES Crop Diseases
BRIEF published on 06/17/2025 at 18:05, 1 year 4 months ago Amoéba obtient l'approbation de sa substance active de biocontrôle en Europe AMOEBA Biocontrôle Agriculture Durable AXPERA Approbation Européenne
BRIEF published on 06/17/2025 at 18:05, 1 year 4 months ago Amoéba obtains approval for its active biocontrol substance in Europe AMOEBA Sustainable Agriculture Biocontrol AXPERA European Approval
PRESS RELEASE published on 06/17/2025 at 18:00, 1 year 4 months ago Amoéba franchit une nouvelle étape décisive avec l'approbation définitive de sa substance active de biocontrôle par la Commission européenne Amoéba obtient l'approbation de sa substance active de biocontrôle par la Commission européenne, marquant une avancée majeure pour sa commercialisation. Détails sur l'efficacité et la durabilité de la substance approuvée AMOEBA Biocontrôle Approbation Commission Européenne AXPERA
PRESS RELEASE published on 06/17/2025 at 18:00, 1 year 4 months ago Amoéba takes another decisive step forward with the final approval of its biocontrol active substance by the European Commission Amoéba receives final approval from European Commission for its biocontrol active substance, AXPERA, after successful validation process confirming low-risk profile AMOEBA European Commission Biocontrol AXPERA Low-risk
BRIEF published on 06/03/2025 at 17:50, 1 year 5 months ago Amoéba et Koppert concluent un accord de distribution pour un biofongicide innovant Innovation Agriculture Durable Distribution Biofongicide Biopesticide
Published on 11/04/2026 at 23:10, 2 hours 18 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 2 hours 28 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 3 hours 13 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 3 hours 23 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 00:02, 1 hour 25 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 5 hours 46 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 6 hours 2 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 6 hours 44 minutes ago EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 7 hours 22 minutes ago Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
Published on 11/04/2026 at 18:00, 7 hours 27 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 7 hours 27 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 7 hours 44 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026